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ABSTRACT 22 
 23 
Background 24 
Although BMI (body mass index) and physical activity are implicated in diabetes 25 
complications, it is unclear how these factors influence personalised care planning linked to 26 
glycaemic control. This study assessed the mediating effects of BMI and physical activity on 27 
relations between personalised care plans (PCPs) and glycated haemoglobin (HbA1c) levels, 28 
using population-based data. 29 
 30 
Method 31 
Bootstrapping was used to analyse PCP, HbA1c, BMI, and physical activity data from 3894 32 
respondents to the 2014 Health Survey for England, for whom HbA1c data was available, 33 
regardless of diabetes status. This group comprised 1812 (46.5%) males, 17 and 2082 34 
(53.5%) females, aged 16 to 90 (Mean = 51.68 years, SD = 17.25).  35 
 36 
Results 37 
Patients with a PCP had higher HbA1c levels compared to those without a care plan. BMI 38 
influenced this relationship amongst patients aged 40 to 60; those with a PCP and higher 39 
HbA1c also tended to have higher BMI values. Physical activity did not affect the relationship 40 
between PCPs and glycaemic control. 41 
 42 
Conclusions 43 
BMI, but not physical activity, partly explained higher HbA1c levels in patients with a PCP. 44 
Given recent population-based evidence implicating exercise in diabetes complications, some 45 
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debate is needed on the role of physical activity in personalised care planning and glycaemic 46 
control.      47 
 48 
KEY POINTS 49 
 Patients with a PCP (personal care plan) have higher HbA1c values. 50 
 BMI partly explains higher HbA1c levels in patients with a PCP.  51 
 Physical activity is not implicated in the relationship between PCPs and HbA1c levels. 52 
 Given that population-based prospective evidence implicates physical activity in 53 
diabetes-related complications, there is need for some debate on the role of physical 54 
activity in personalised care planning and glycaemic control. 55 
 56 
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INTRODUCTION 71 
Blood glucose control is a critical aspect of diabetes care (Jia, 2016). People with diabetes, or 72 
individuals experiencing hyperglycaemia (Godoy et al., 2012, Farrokhi et al., 2011) may be 73 
offered personal care plans (PCPs) (Coulter et al., 2013) to help them manage their blood 74 
glucose (Diabetes UK, 2009). A PCP usually consists of a written document outlining 75 
specific goals, and activities designed to achieve these objectives (Diabetes UK, 2009, 76 
Coulter et al., 2013, The Health Developer Network, 2016). PCPs reflect a partnership 77 
between the doctor/nurse and their patients (Diabetes UK, 2017), are essential for effective 78 
self-management (Jansen et al., 2015, Tarkin et al., 2008), and have been implicated in 79 
improved patient outcomes (Hird et al., 2015, Russell et al., 2008).  80 
PCPs are presumed to play an important role in HbA1c (glycated haemoglobin) levels 81 
(Diabetes UK, 2009). Setting clear goals for glycaemic control (e.g., achievable HbA1c 82 
targets), and designating specific actions to attain these objectives (e.g., weekly participation 83 
in a local sports programme), can help patients initiate and sustain key lifestyle changes 84 
essential for reducing HbA1c (Coulter et al., 2013). A recent Cochrane review of the effects of 85 
personalised care planning in adults with long-term conditions found HbA1c levels to be 86 
0.24% lower in patients with a PCP, compared to those receiving usual care (Coulter et al., 87 
2015). Thus, HbA1c level is an important criterion that GPs consider in deciding which 88 
patients to offer a PCP (Diabetes UK, 2017).  89 
In 2015 Diabetes UK launched an ‘Information Prescription’ scheme to ensure 90 
diabetes patients who fail to meet HbA1c, blood pressure and cholesterol targets receive a 91 
one-page PCP containing specific action plans for improving metabolic control (e.g., 92 
reducing dietary fat, performing 150 minutes of moderate aerobic activity per week, and 93 
strength exercises ≥ 2 days per week) (Diabetes UK, 2017, Diabetes UK, 2015a). Patients 94 
with high blood pressure, high total cholesterol-to-HDL (high density lipoprotein) ratios, and 95 
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high HbA1c have a greater risk of developing complications, and hence are likely to benefit 96 
from personalised care (Diabetes UK, 2017). Information prescriptions are integrated into 97 
primary care IT systems, such as EMIS Web, so that GPs receive an automated alert if a 98 
specific patient is failing to meet their metabolic targets (Diabetes UK, 2015b). Diabetes UK 99 
literature suggests over 1000 diabetes patients a month use information prescriptions to 100 
manage their condition (Diabetes UK, 2015a). Information prescriptions can be considered a 101 
specific IT-based PCP designed to improve glycaemic control in diabetes patients with a high 102 
risk of complications (Diabetes UK, 2015a). 103 
Glycaemic control is influenced by BMI (body mass index) and physical activity 104 
(Malnick and Knobler, 2006, Hu et al., 2014, Bhupathiraju and Hu, 2016, Gay et al., 2016, 105 
Cuenca-Garcia et al., 2012, Hamer et al., 2014). Lower BMI values are associated with better 106 
HbA1c outcomes (Patiakas and Charalampous, 2010, Senechal et al., 2013, Diels et al., 2014). 107 
For example, one study of type 2 diabetes patients found that a decrease in waist 108 
circumference, and increased physical fitness, was associated with an increased likelihood of 109 
significant HbA1c reductions (> 0.5%) (Senechal et al., 2013). A prospective study of data 110 
from a 1958 birth cohort revealed that early onset of overweight/obesity was implicated in a 111 
23.9-fold increased risk of a HbA1c value ≥ 7% (Power and Thomas, 2011). An investigation 112 
of 2707 adults at risk from type 2 diabetes implicated higher amounts of moderate-to-113 
vigorous physical activity in lower HbA1c values (Gay et al., 2016). Moderate-to-vigorous 114 
has been found to predict improved metabolic outcomes, including HbA1c levels, in healthy 115 
adults (Hamer et al., 2014). 116 
BMI and physical activity affect the risk of complications in diabetes patients (Segula, 117 
2014, Blomster et al., 2013). For example, obesity (i.e., BMI ≥ 30) is strongly implicated in 118 
cardiovascular disease (Wilson et al., 2002), high blood pressure (Segula, 2014), and higher 119 
levels of LDL cholesterol (Varbo et al., 2015). Physical inactivity has been linked to impaired 120 
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renal function, increasing retinopathy, and other complications, in patients with type 1 121 
diabetes (Waden et al., 2008). Evidence from a long-term prospective study of over 11,000 122 
patients with type 2 diabetes found that moderate-to-vigorous levels of physical activity (of at 123 
least 15 minutes per week) at baseline was associated with a reduced incidence of 124 
cardiovascular events, microvascular complications, and mortality rates, over a 5-year period 125 
(Blomster et al., 2013). 126 
Despite evidence implicating BMI/physical activity in HbA1c levels (Senechal et al., 127 
2013, Quirk et al., 2014), and diabetes complications (Blomster et al., 2013, Waden et al., 128 
2008, Segula, 2014), it is unclear the extent to which these factors influence the relationship 129 
between PCPs and glycaemic control (Diabetes UK, 2017). Although BMI and physical 130 
activity are not part of the criteria for offering information prescriptions to patients, (Diabetes 131 
UK, 2015a), they nevertheless constitute key lifestyle changes recommended for lowering 132 
HbA1c  in personalised care planning (Diabetes UK, 2009, Diabetes UK, 2015a). Thus, it 133 
follows that HbA1c reductions associated with having a PCP will be partly attributable to 134 
changes in BMI and/or levels of physical activity. Similarly, poor weight control, and/or 135 
failure to adhere to physical activity targets, may negative the influence of PCPs on 136 
glycaemic control.  137 
Nurses typically form part of health care teams who work in partnership with patients 138 
to arrange and monitor PCPs (Coulter et al., 2013), including information prescriptions 139 
(Diabetes UK, 2015b, Diabetes UK, 2017). Guidance published by Diabetes UK makes 140 
provision for a health professional to be named on information prescriptions, with a statement 141 
specifically inviting patients to discuss and agree achievable HbA1c targets with a doctor or 142 
nurse (Diabetes UK, 2015a). There is particular emphasis on controlling HbA1c levels, in 143 
order to reduce the risk of complications (Diabetes UK, 2015a). Prescriptions makes specific 144 
reference to lifestyle factors, meaning patient consultations are likely to involve 145 
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conversations about BMI/physical activity, in relation to glycaemic control (Diabetes UK, 146 
2015a). As both BMI and physical activity contribute significantly to HbA1c, and related 147 
complications (Segula, 2014, Bhupathiraju and Hu, 2016, Blomster et al., 2013), it is 148 
essential to better understand how these factors influence the relationship between PCPs and 149 
HbA1c levels (Diabetes UK, 2015a).  150 
 151 
AIM 152 
This study had two objectives. The first was to establish the association between PCPs and 153 
HbA1c levels. Current literature suggests HbA1c can be both a precursor and outcome of 154 
PCPs. In the former scenario HbA1c level is used as a criterion for offering PCPs to patients 155 
(Diabetes UK, 2015a, Diabetes UK, 2015b). In the latter situation, PCPs can help patients 156 
lower their HbA1c level (Coulter et al., 2015). Both directions of causality are valid. For the 157 
purposes of this paper, PCP status (i.e., whether or not a patient has a PCP) was treated as the 158 
‘predictor’ variable, and HbA1c as the ‘outcome’ measure. This is consistent with a primary 159 
objective of personalised care – to improve glycaemic control (Coulter et al., 2015) – but 160 
does not preclude the use of HbA1c as a basis for offering PCPs to patients (Diabetes UK, 161 
2015a, Diabetes UK, 2017). The second objective was to determine the extent to which BMI 162 
and physical activity explain any relationship between PCPs and HbA1c levels.  163 
It was expected that (a) patients with PCPs will have lower HbA1c levels compared to 164 
patients who had not agreed a care plan, and (b) BMI and physical activity will be implicated 165 
in this relationship, as mediating factors, such that the relationship between PCPs and HbA1c 166 
is partly explained by BMI and physical activity. Thus, for example, lower HbA1c values in 167 
patients with a PCP may partly reflect lower BMI scores, and/or greater physical activity 168 
levels in such patients. These hypotheses were tested both prior to and following adjustments 169 
for selected covariates, including diabetes status. 170 
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METHOD 171 
 172 
Sample and procedure 173 
This study analysed data on PCP status, HbA1c, BMI, and physical activity, obtained from the 174 
2014 Health Survey for England (HSE), an annual exercise that assesses health-related 175 
parameters and lifestyle factors in children and adults (Health Survey for England, 2014). 176 
The survey is commissioned by the Health and Social Care Information Centre, and consists 177 
of an interview (including self-administered questionnaires), followed by a visit by a nurse to 178 
collect biomedical data. The 2014 survey was completed by 8,077 adults (aged 16 and over), 179 
and over 2000 children (aged 0 to 15). The study reported here analysed data from 3894 180 
adults for whom HbA1c data was available. This group comprised 1812 (46.5%) males, and 181 
2082 (53.5%) females, aged 16 to 90 (Mean = 51.68 years, SD = 17.25). The sample (92%) 182 
was predominantly Caucasian. 183 
 184 
Measures 185 
Glycated haemoglobin (HbA1c) was based on non-fasting blood samples, and (for this 186 
study) calibrated in mmol/mol. HbA1c data provides a measure of average blood glucose 187 
levels over the previous three months (Jia, 2016).  188 
PCP status was assessed via two questions. Firstly, respondents were asked if (a) they 189 
had ever had a PCP-related discussion with a doctor/nurse regarding a long-term condition, 190 
‘Yes’ (1)/ ‘No or not sure’ (0); and (b) whether they had agreed a PCP with a health 191 
professional during the past 12 months, 'no PCP agreed' (0)/ 'agreed a PCP < or > 12 months 192 
ago' (1). Responses to both items were combined to form a PCP index, with a higher 193 
indicating a better PCP status (e.g., discussed and/or agreed a PCP).  194 
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Physical activity was measured using the short IPAQ (International Physical Activity 195 
Questionnaire) (Booth, 2000). The IPAQ/Short assesses three activity levels – walking, 196 
moderate-intensity, and vigorous-intensity – across several domains (leisure time, 197 
domestic/gardening, work/transport-based). Respondents receive a score for each level, 198 
reflecting a summation of duration (minutes) and frequency (days). For the purposes of this 199 
study, six separate scores were evaluated: total number of minutes usually spent per day, and 200 
in the last 7 days, doing (a) ‘vigorous-intensity’ activities, (b) ‘moderate-intensity’ activities, 201 
and (c) walking. 202 
BMI was computed by dividing weight in kilograms by the square of height in metres 203 
(kg/m2) (Nuttall, 2015). Adults (aged > 16) were classified into the following groups: Less 204 
than 18.5 ‘Underweight’; 18.5 to less than 25 ‘Normal’; 25 to less than 30 ‘Overweight’; 30 205 
or more ‘Obese’; 40 or more ‘Morbidly obese’. The present study evaluated raw BMI scores, 206 
for the purposes of hypotheses testing, and BMI groups (excluding the underweight category, 207 
and combining obese and morbidly obese groups) for descriptive statistics.  208 
Other variables assessed included blood pressure, and diabetes status. Blood pressure 209 
was assessed using the Omron HEM 907 blood pressure monitor. Respondents were 210 
classified into three groups: BP under 130/80, BP under 140/90, but not under 130/80, and 211 
BP over 140/90. Respondents also indicated whether they had been diagnosed with high 212 
blood pressure by a doctor; ‘Yes’ (1), ‘No’ (2). Diabetes status was assessed by asking 213 
respondents if they currently have or have ever had diabetes, ‘Yes’ (1)/ ‘No’ (0).  214 
 215 
…………………………………… 216 
Insert Table 1 about here 217 
…………………………………… 218 
 219 
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 229 
RESULTS 230 
Descriptive statistics (means/SD) are presented in Table 1. PCP data was available for 42.7% 231 
(n = 1662) respondents. The vast majority of this subgroup (87.7%) had not agreed a PCP 232 
with a health professional, while the remainder (12.3%) had agreed a PCP with a 233 
doctor/nurse, ≤ or ≥ 12 months ago. These groups did not differ on measures physical activity 234 
(both groups achieved the recommended ≥ 150 minutes of moderate-intensity activity), BMI 235 
score (both groups classified as ‘Overweight’), mental wellbeing score, or gender 236 
distribution. There were also no group differences in the proportion who had been diagnosed 237 
with high blood pressure by a doctor/nurse (over 98% of respondents had received this 238 
diagnosis), and the proportion receiving earnings from employment or self-employment. 239 
However, patients who had agreed a PCP were slightly younger, more likely to have been 240 
diagnosed with diabetes, and had higher blood glucose levels (HbA1c).   241 
Table 2 shows the bivariate associations between variables. Patients who had 242 
discussed and agreed a PCP with their doctor were younger, generated higher HbA1c values, 243 
more likely to have been diagnosed with diabetes, and performed fewer minutes of moderate-244 
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intensity physical activity during the previous 7 days. In addition to denoting diabetes status, 245 
higher HbA1c values were associated with greater BMI, and fewer minutes of physical 246 
activity per day/week. Higher BMI values also depicted older age, doctor-diagnosed HBP, 247 
having ever had diabetes, and fewer minutes of physical activity. Gender differences are also 248 
noteworthy: overall, females had lower blood pressure, and lower levels of light (i.e., 249 
walking), moderate-, and vigorous-intensity physical activity per day, and during the past 7 250 
days. 251 
 Hypothesis testing was performed using a bootstrapping SPSS dialogue (Hayes, 2013, 252 
Hayes, 2009). Bootstrapping was performed separately for each of the following age-related 253 
subgroups: aged up to 39; over 40; over 50; and over 60. In each bootstrapping model HbA1c 254 
(mmol/mol) was entered as the outcome (‘Variable Y’), while PCP status was treated as the 255 
predictor (‘Variable X’). BMI and the six IPAQ/physical activity levels, were treated as 256 
mediator variables (‘Variables M’). Diabetes status (whether participants had ever had 257 
diabetes), blood pressure (doctor-diagnosed), and gender, were treated as control variables 258 
(i.e., covariates). The conservative Sobel test was used to determine mediation. Results are 259 
shown in Tables 3 and 4. 260 
0 to 39 years. PCP status directly predicted glycaemic control, such that people who 261 
had agreed a PCP had higher HbA1c values compared to those without a PCP. Neither BMI 262 
nor physical activity mediated this relationship.  263 
Over 40 years. PCP status directly predicted HbA1c; patients with a PCP tended to 264 
have poorer glycaemic control. This relationship was mediated by BMI, whereby patients 265 
who had a care plan had both higher BMI and higher HbA1c values, compared to those 266 
without a plan. This depicted a mediator effect because greater BMI was also associated with 267 
higher HbA1c levels (see Figure 1). This indirect effect was significant based on the 268 
conservative Sobel test (z = 2.15, p <0.05), and accounted for 13.1% of the total effect of 269 
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PCP status on HbA1c. Controlling for diabetes status and other covariates attenuated the 270 
indirect effect (Sobel test p > 0.05), but did not completely abolish it (see Table 3).  271 
Over 50 years. Having a PCP was associated with higher HbA1c levels in this group. 272 
This association was mediated by BMI, whereby those with a care plan had higher BMI, and 273 
poorer glycaemic control, compared to people without a PCP (see Figure 2). The Sobel test 274 
for this indirect effect was significant (z = 2.06, p <0.05). The mediator effect accounted for 275 
18.2% of the total effect of PCP status on HbA1c. Adjusting for covariates weakened but did 276 
not entirely negate the indirect effect (Table 3).  277 
Over 60 years. Although having a PCP predicted higher HbA1c values, neither BMI 278 
nor physical activity mediated this relationship.  279 
…………………………………… 280 
Insert Figure 1 about here 281 
…………………………………… 282 
…………………………………… 283 
Insert Figure 2 about here 284 
…………………………………… 285 
DISCUSSION 286 
Contrary to what was hypothesised patients with a PCP had higher HbA1c levels. However, 287 
higher BMI scores partly explained this relationship (see Figures 1 and 2). Previous research 288 
has implicated BMI in elevated HbA1c (Power and Thomas, 2011, Senechal et al., 2013, 289 
Patiakas and Charalampous, 2010). Interestingly, there was no evidence implicating physical 290 
activity in PCP – HbA1c relations, despite previous studies associating exercise with 291 
glycaemic control (Umpierre et al., 2011, Gay et al., 2016, Hamer et al., 2014).  292 
Previous research has implicated PCPs in lower HbA1c (Coulter et al., 2015). An obvious 293 
explanation for the higher HbA1c levels observed here is the mediating effect of BMI. It is 294 
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possible PCPs may lead to elevated HbA1c values, if patients are gaining weight, perhaps due 295 
to noncompliance with PCP targets or action plans, and/or other factors, such poor doctor-296 
patient interaction (Paternotte et al., 2015). Previous research shows a strong connection 297 
between higher BMI scores and higher HbA1c, with one study linking elevated BMI scores in 298 
childhood to a 23.9-fold increased risk of a HbA1c ≥ 7% later in life (Power and Thomas, 299 
2011). Thus, patients with high HbA1c/BMI stand to benefit considerably from information 300 
prescriptions (Diabetes UK, 2015a) and other forms of personalised care (Coulter et al., 301 
2013) that specifically target weight control. The fact that BMI mediated the PCP – HbA1c 302 
relationship specifically in 40 to 60 year olds suggests BMI plays a particularly important 303 
role in personalised care and glycaemic control in middle-aged patients (Owen et al., 2015). 304 
Another possible explanation for the higher HbA1c levels in patients with PCPs is that 305 
care plans tend to be offered to patients with poorer glycaemic control (Diabetes UK, 2015a). 306 
Offering PCPs to people with higher HbA1c reflects current recommendations that 307 
information prescriptions should target individuals at high risk of complications (i.e., high 308 
HbA1c) (Diabetes UK, 2017). The mediating effect of BMI may simply reflect the fact that 309 
patients with high HbA1c also tend to have high BMI scores (Power and Thomas, 2011), 310 
and/or that GPs are simply more likely to offer PCPs to patients exhibiting both risk factors 311 
(Diabetes UK, 2009).  312 
The fact that physical activity did not affect relations between PCPs and HbA1c is 313 
worrying given that inactivity significantly increases the risk of complications (Waden et al., 314 
2008, Blomster et al., 2013). Evidence from a long-term prospective study associates 315 
moderate-to-vigorous levels of activity with a reduced risk of cardiovascular problems, 316 
microvascular complications, and premature mortality (Blomster et al., 2013). Although other 317 
research suggests no link between exercise and complications (Makura et al., 2013), the 318 
availability of population-based prospective data (Blomster et al., 2013) suggests physical 319 
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inactivity should be an important factor in personalised care planning and glycaemic control. 320 
This seems particularly relevant to middle-aged/older patients. This demographic may find 321 
moderate-to-vigorous intensity exercises (e.g., fast cycling, running) particularly challenging, 322 
especially if conducted on a regular basis (Sparling et al., 2015), negating the glycaemic 323 
benefits (Kennedy et al., 2013). Other factors, such as increased calorie intake, or variations 324 
in insulin dosage, may also attenuate the effect of physical activity on HbA1c, and should be 325 
carefully explored by doctors and patients when setting up PCPs (Kennedy et al., 2013).  326 
This study has some limitations. Firstly, while BMI mediated the PCP – HbA1c 327 
association, BMI is a poor index of body fat, or morbidity and mortality risk (Nuttall, 2015). 328 
Another problem is that data analysis did not control for every covariate relevant to PCP 329 
status, BMI, and HbA1c (e.g., dietary intake, or insulin resistance). Additionally, there is 330 
uncertainty regarding the actual content of PCPs agreed with patients in this data set; due to 331 
the personalised nature of PCPs, the HSE does include individual HbA1c targets, or 332 
recommended lifestyle changes. Furthermore, the HSE data analysed here pre-dates the 333 
launch of information prescriptions by Diabetes UK (Diabetes UK, 2015b). As this new 334 
personalised care tool is IT-based and can be deployed in a matter of minutes (Diabetes UK, 335 
2017), it’s impact on glycaemic control may be more dramatic than more generic PCP 336 
formats (Coulter et al., 2013). Finally, the cross-sectional nature of the design precludes 337 
inferences about the possible direction of causality. 338 
This is the first study to examine how BMI and physical activity influence relations 339 
between personalised care planning and glycaemic control (Diabetes UK, 2017). The study 340 
suggests BMI partly explains higher HbA1c levels in patients with a PCP. The irrelevance of 341 
physical activity in this context is worrying given recent population-based prospective 342 
evidence implicating exercise intensity in diabetes complications (Blomster et al., 2013). 343 
These findings are particularly important given the current emphasis on the use of 344 
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information prescriptions to improve patient outcomes (Diabetes UK, 2015b). If physical 345 
activity level is a precursor for complications (Blomster et al., 2013), then there needs to be 346 
some debate amongst doctors/nurses, in partnership with patients, on the role of exercise in 347 
personalised care regarding glycaemic control. 348 
 349 
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Figure 1 Mediating effect of BMI on the PCP – HbA1c association in patients aged ≥ 40 493 
(ap<0.05, cp<0.01, bp<0.001) 494 
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Figure 2 Mediating effect of BMI on the PCP – HbA1c association in patients aged ≥ 50 498 
(ap<0.05, cp<0.01, bp<0.001) 499 
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Table 1 – Descriptive statistics by PCP status. 506 
 507 
         
   PCP status  
         
 Variables  No PCP agreed  Agreed PCP < or > 12 months 
ago 
 P  
         
         
 Sample size (%)  1458 (87.7%)  204 (12.3%)    
 Age  57.85 (16.87)  55.08 (15.94)  t(1660) = 2.25, p<0.05  
 Gender (Male/Female)  638 (86.8%)/820 (88.5%)  97 (13.2%)/107 (11.5%)  Not Significant  
 HbA1c (mmol/mol)  39.67 (10.32)  42.07 (13.98)  t(1660) = -2.36, p<0.05  
 BMI (Body mass index)  28.52 (5.52)  29.13 (6.05)  Not Significant  
 Diabetes status (currently have, or ever had 
diabetes) (Yes/No) 
 172 (11.8%)/1284 (88.2%)  37 (18.1%)/167 (81.9%)  χ(1) = 6.50, p <0.01  
 High blood pressure – doctor diagnosed 
(Yes/No) 
 585 (98%)/12 (2%)  82 (98.8%)/1(1.2%)  Not Significant  
 Minutes VPA per day  57.62 (106.13)  52.20 (104.47)  Not Significant  
 Minutes MPA per day   64.00 (103.14)  50.33 (85.31)  Not Significant  
 Minutes Walking per day   78.18 (99.62)  85.04 (118.45)  Not Significant  
 Minutes VPA per week   214.06 (542.67)  217.42 (578.30)  Not Significant  
 Minutes MPA per week   279.64 (581.86)  212.51 (482.57)  Not Significant  
 Minutes Walking per week   424.20 (624.99)  456.83 (749.69)  Not Significant  
         
 508 
Figures show the mean (+ standard deviation) or count (+ percentage). PCP = Personal care plan (status); MPA = Moderate-intensity activity; VPA = Vigorous-intensity 509 
activity; BMI = Body mass index.  510 
 511 
 512 
 513 
 514 
 515 
 516 
 517 
 518 
 519 
 520 
 521 
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Table 2 Bivariate correlations and descriptive statistics 522 
               
Variables (1) (2) (3) (4) (5) (6) (7) (8) (9) (10) (11) (12) (13) (14) 
               
               
1) PCP index -              
2) Age -0.057a -             
3) Gender (M/F) -0.037 0.011 -            
4) HbA1c  mmol/ml 0.088b 0.297b -0.016 -           
5) HBP (doctor) -0.002 0.381b -0.034a 0.255b -          
6) Diabetes (Y/N) 0.086b 0.165b -0.022 0.599b 0.203b -         
7) BMI score 0.047 0.163b -0.029 0.249b 0.225b 0.178b -        
8) VPA min p/d -0.025 -0.111b -0.177b -0.030 -0.071b -0.038a -0.049b -       
9) MPA min p/d -0.041 -0.074b -0.135b -0.053b -0.063b -0.061b -0.026 0.474b -      
10) WK min p/d 0.012 -0.104b -0.075b -0.057b -0.082b -0.033 -0.057b 0.345b 0.361b -     
11) VPA min p/w -0.029 -0.096b -0.173b -0.023 -0.063b -0.041a -0.034a 0.907b 0.454b 0.340b -    
12) MPA min p/w -0.057a -0.075b -0.131b -0.039a -0.052b -0.047b -0.010 0.443b 0.905b 0.368b 0.485b -   
13) WK min p/w 0.002 -0.111b -0.073b -0.062b -0.086b -0.036a -0.059b 0.345b 0.369b 0.945b 0.360 b 0.404b -  
14)  ≥ 30 min of 
MPA/VPA p/wk 
-0.020 -0.225b -0.106b -0.171b -0.155b -0.116b -0.138b 0.420b 0.431b 0.164b 0.311b 0.335b 0.156b - 
               
 523 
Note. HBP (High Blood Pressure), BMI (Body Mass Index), VPA (Vigorous-intensity physical activity), MPA (Moderate-intensity physical activity), 524 
WK (Walking), p/d (per day), p/w (per week). HBP reflects doctor-diagnosed cases. All physical activity variables denote total number of minutes spent 525 
on the specified activity. Superscripts: a p < .05, bp < .01, cp < .001.  526 
 527 
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 529 
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 537 
 538 
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 539 
Table 3 – Mediating effects of BMI and physical activity on the PCP – HbA1c association, before and after adjusting for diabetes status and other covariates. 540 
 541 
           
   Age groups 
           
Regression pathways  0-39 Over 40 Over 50 Over 60 
           
   Effect (CI) Effect (CI) Effect (CI) Effect (CI) 
           
           
Total effect of PCP on HbA1c  1.58a (0.34, 2.82) 1.84a (0.87, 2.81) 1.46a (0.39, 2.52) 1.60a (0.45, 2.74) 
          
Direct effect of PCP on HbA1c  1.53a (0.28, 2.78)  1.57a (0.62, 2.53) 1.20a (0.15, 2.24) 1.48a (0.37, 2.59) 
           
Indirect effect of PCP on HbA1c via;          
          
 Minutes VPA per day   0.03 (-0.16, 0.64) -0.02 (-0.18, 0.02) -0.03 (-0.22, 0.03) -0.00 (-0.23, 0.05) 
 Minutes MPA per day   -0.28 (-0.84, 0.02) 0.06 (-0.02, 0.23) 0.05 (-0.01, 0.26) -0.01 (-0.23, 0.04) 
 Minutes Walking per day   0.18 (-0.03, 1.16) 0.00 (-0.11, 0.31) 0.00 (-0.09, 0.18) -0.01 (-0.24, 0.04) 
 Minutes VPA past week   -0.01 (-0.48, 0.22) -0.01 (-0.14, 0.05) -0.01 (-0.20, 0.04) -0.00 (-0.15, 0.08) 
 Minutes MPA past week   0.29 (-0.02, 0.72) -0.00 (-0.13, 0.13) -0.01 (-0.19, 0.09) 0.00 (-0.05, 0.12) 
 Minutes Walking past week   -0.18 (-1.01, 0.03) -0.00 (-0.26, 0.12) -0.00 (-0.10, 0.07) -0.01 (-0.18, 0.06) 
 BMI (body mass index)  0.02 (-0.10, 0.23) 0.24a (0.03, 0.48) 0.26a (0.05, 0.56) 0.17 (-0.08, 0.49) 
           
 542 
ap<0.05 or CI range excludes ‘0’. PCP = Personal care plan (status) ; MPA = Moderate-intensity activity ; VPA = Vigorous-intensity activity. BMI = Body mass index. 543 
For simplicity the table does not include the effects of variable X (PCP) on variables M (physical activity, BMI), and effects of variables M on variable Y (HbA1c).  544 
 545 
546 
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Table 4 – Mediating effects of BMI on the PCP – HbA1c association, before and after adjusting for diabetes status and other covariates. 547 
 548 
       
   Age groups 
       
Regression pathways  Over 40 Over 50 
       
   Effect CI Effect CI 
      
       
Total effect of PCP on HbA1c  0.78a (0.02, 1.54) 0.72 (-0.12, 1.58) 
      
Direct effect of PCP on HbA1c  0.71 (-0.05, 1.47) 0.66 (-0.18, 1.52) 
       
Indirect effect of PCP on HbA1c via;      
      
 BMI (body mass index)  0.07a (0.00, 0.18) 0.09a (0.01, 0.25) 
       
 549 
ap<0.05 or CI range excludes ‘0’. Lower confidence interval for the BMI effect in the ‘over 40 group’ exceeded zero (0.003). For simplicity only the significant 550 
mediator variable (BMI) is included here; the table does not include the other M variables. 551 
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